These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

307 related items for PubMed ID: 16936157

  • 41. A population-based study of the effect of the HFE C282Y and H63D mutations on iron metabolism.
    Njajou OT, Houwing-Duistermaat JJ, Osborne RH, Vaessen N, Vergeer J, Heeringa J, Pols HA, Hofman A, van Duijn CM.
    Eur J Hum Genet; 2003 Mar; 11(3):225-31. PubMed ID: 12673276
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Prevalence, characteristics, and prognostic significance of HFE gene mutations in type 2 diabetes: the Fremantle Diabetes Study.
    Davis TM, Beilby J, Davis WA, Olynyk JK, Jeffrey GP, Rossi E, Boyder C, Bruce DG.
    Diabetes Care; 2008 Sep; 31(9):1795-801. PubMed ID: 18566337
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Comparison of the unsaturated iron-binding capacity with transferrin saturation as a screening test to detect C282Y homozygotes for hemochromatosis in 101,168 participants in the hemochromatosis and iron overload screening (HEIRS) study.
    Adams PC, Reboussin DM, Leiendecker-Foster C, Moses GC, McLaren GD, McLaren CE, Dawkins FW, Kasvosve I, Acton RT, Barton JC, Zaccaro D, Harris EL, Press R, Chang H, Eckfeldt JH.
    Clin Chem; 2005 Jun; 51(6):1048-52. PubMed ID: 15833784
    [No Abstract] [Full Text] [Related]

  • 46. Mutations of the hemochromatosis gene in Italian candidate blood donors with increased transferrin saturation.
    Velati C, Marlianici E, Rigamonti D, Barillari G, Chiavilli F, Fugiani P, Garozzo G, Lancieri M, Rinaldi S, Testa D, Sampietro M, Tavazzi D, Delbini P, Fargion S, Fiorelli G.
    Hematol J; 2003 Jun; 4(6):436-40. PubMed ID: 14671617
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. Biological variability of transferrin saturation and unsaturated iron-binding capacity.
    Adams PC, Reboussin DM, Press RD, Barton JC, Acton RT, Moses GC, Leiendecker-Foster C, McLaren GD, Dawkins FW, Gordeuk VR, Lovato L, Eckfeldt JH.
    Am J Med; 2007 Nov; 120(11):999.e1-7. PubMed ID: 17976429
    [Abstract] [Full Text] [Related]

  • 51. CYBRD1 as a modifier gene that modulates iron phenotype in HFE p.C282Y homozygous patients.
    Pelucchi S, Mariani R, Calza S, Fracanzani AL, Modignani GL, Bertola F, Busti F, Trombini P, Fraquelli M, Forni GL, Girelli D, Fargion S, Specchia C, Piperno A.
    Haematologica; 2012 Dec; 97(12):1818-25. PubMed ID: 22773607
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. HFE mutations, iron deficiency and overload in 10,500 blood donors.
    Jackson HA, Carter K, Darke C, Guttridge MG, Ravine D, Hutton RD, Napier JA, Worwood M.
    Br J Haematol; 2001 Aug; 114(2):474-84. PubMed ID: 11529872
    [Abstract] [Full Text] [Related]

  • 54. Accuracy of family history of hemochromatosis or iron overload: the hemochromatosis and iron overload screening study.
    Acton RT, Barton JC, Passmore LV, Adams PC, McLaren GD, Leiendecker-Foster C, Speechley MR, Harris EL, Castro O, Reiss JA, Snively BM, Harrison BW, McLaren CE.
    Clin Gastroenterol Hepatol; 2008 Aug; 6(8):934-8. PubMed ID: 18585964
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Hemochromatosis (HFE) gene splice site mutation IVS5+1 G/A in North American Vietnamese with and without phenotypic evidence of iron overload.
    Steiner M, Leiendecker-Foster C, McLaren GD, Snively BM, McLaren CE, Adams PC, Eckfeldt JH.
    Transl Res; 2007 Feb; 149(2):92-5. PubMed ID: 17240320
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. A population-based study of the biochemical and clinical expression of the H63D hemochromatosis mutation.
    Gochee PA, Powell LW, Cullen DJ, Du Sart D, Rossi E, Olynyk JK.
    Gastroenterology; 2002 Mar; 122(3):646-51. PubMed ID: 11874997
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.